-
Most Popular
Search Results
176 results for yuii
Jaguar Health Stock Remains a Speculative Investment At Best
Jaguar Health stock is a speculative investment at best. JAGX stock is hard to nail down as it’s hard to understand its numerous and strange…
Sundial Grower’s Acquisition Changes Little for Investors
SNDL stock will remain a dog until it isn’t. It can expand its network but operational efficiency, not scale, is the issue.
Don’t Try to Tame Jaguar Health Stock As It Rips Higher
If you believe in the future of plant-based medical treatments, then a long position in JAGX stock could offer exposure to this technology.
The Value of Living Longer
Altos Labs has revealed a funding round of $3 billion dollars, much larger than any previous longevity funding. Here’s what you need to know.
Will Cardano Keep Ascending? That’s the $80 Billion Question.
Bloomberg reported Aug. 16 that Cardano was the world’s third-largest cryptocurrency. ADA-USD has been on a roll. Is it bound for a cooldown?
Progenity Stock May Not Be a Great Short-Squeeze Play, But It Has Potential
Traders might obsesses over PROG stock’s short-squeeze potential, but instead they should consider Progenity’s huge addressable market.
Sundial’s Alcanna Acquisition Could Be a Game-Changer
Investors haven’t given SNDL stock its due following the company’s impressive turnaround. A recent acquisition could change that.
Do We Know Enough About Napo Pharma’s SPAC To Invest In Jaguar Health?
Jaguar Health might merge part of its Napo Pharmaceuticals unit with a SPAC. What’s this mean for JAGX stock over the long haul?
Sorrento Therapeutics Is Betting On A Longer Play, So Should You
The delay of Sorrento Therapeutics’ Covid-19 vaccine has weakened SRNE stock, but the company has plenty more in the pipeline.
The Market is Ignoring the Full Success and Potential of Nintendo’s Switch
NTDOY stock may be in a freefall right now, but not because Nintendo’s not doing its part to sell games and consoles.
Value-Added Acquisition Clears the Runway for Miragen Therapeutics
It was thrilling to watch MGEN stock spike, and the bull move might not be over as Miragen’s new acquisition puts high-need medicine in focus.
7 – 8 of 176 results